Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Clinical trial NCT06974110 · RECRUITING

Trial details

NCT number: NCT06974110
Sponsor: MOMA Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Metastatic Solid Tumor Endometrial Cancer MSI-H Cancer Colorectal Cancer Gastric Cancer dMMR Cancer

Start date: 2025-07-16
Primary completion: 2027-11-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.